During the past decade, Visual Eyes conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 11 clinical trials were completed, i.e. on average, 84.6% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 9 clinical trials were completed. i.e. 81.8% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Visual Eyes" are "Visual Acuity" (12 trials) and "Vision Disorders" (1 trials). Many other conditions were trialed in "Visual Eyes" in a lesser frequency.

Most popular intervention types in "Visual Eyes" are "Device" (13 trials). Other intervention types were less common.

The name of intervention was led by "Dailies Total 1® Multifocal Contact Lens" (2 trials), "Dailies Total 1® Multifocal Contact Lenses" (2 trials), "senofilcon A C3" (2 trials), "ACUVUE OASYS® with HYDRACLEAR® PLUS" (1 trials) and "ACUVUE Oasys 1-Day" (1 trials). Other intervention names were less common.

The vast majority of trials in "Visual Eyes" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Visual Eyes". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Visual Eyes, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Visual Eyes, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 13 trials that are defined as “Not Applicable".